TB under the microscope

  • April 18, 2012
TB under the microscope

A new organisation will bring together experts on global health to tackle major diseases.

The chief medical officer of pharmaceutical giant GlaxoSmithKline will give the keynote address at a conference dedicated to finding new ways to tackle diseases which disproportionately affect developing countries.

The Cambridge Global Health Commercialization & Funding Roundtable has been organised by three Gates Cambridge scholars and two other students and takes place this Thursday and Friday.

Ellen Strahlmanfrom GlaxoSmithKline will give the keynote address on Thursday and Friday is reserved for a series of panel discussions on the theme of tuberculosis, including social entrepreneurship in TB delivery, global health funding and TB vaccines.

Among those taking part are Christopher Dye, Director of Health Information in the Office of HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases at the World Health Organization; Patrick Gihana-Mulenga, the Rwanda High Commission Commercial Attaché; Bina Rawal, Head of Clinical Development in the Technology Transfer Division of the Wellcome Trust; Davino Sena, Head of Science and Technology at the Embassy of Brazil in London; Shelly Batra, President of OperationASHA; Suresh Jadhav, Executive Director of the Serum Institute of India Ltd; and David Brown, Adviser of One World Health. Global experts in tackling health problems, including academics, funding and investment companies, biotechnology companies and vaccine manufacturers are also taking part.

Gates Cambridge scholar Julia Fan Li [2008] is the chairperson of the GHCF Roundtable. The organising team is Priya Khetarpal, Tomas Niklitschek and Gates Cambridge scholars Nicole Person-Rennell [2011] and Diana Pirjol [2011].

The Roundtable was set up to examine entrepreneurial activity in global health and to explore opportunities and business models to reconcile healthcare innovation and access. It brings together entrepreneurs, scientists, civil society, investors, funders, academics and ecosystem participants to explore business models in the discovery, development and delivery of global health innovations.

Its aims include sharing best practices of existing business models, stimulating new thinking upon the catalytic resource providers of both grant and investment-funding and encouraging awareness and public engagement on the issue of global health.

“We are really excited to be examining biomedical innovation from a holistic perspective.” says Julia Fan Li, “and pleased to welcome passionate global health experts from all over the world to Cambridge.”

For more information, click here.

Photo credit: Creative Commons, Ray Butler, CDC and Microbe World.

Latest News

Scholar recognised for research into misinformation

A Gates Cambridge Scholar has been shortlisted for a Women of the Future Award for her research into countering misinformation. Melisa Basol [2018] was shortlisted for the science category of the UK Awards which recognises “truly remarkable female scientists, forging new ground in research and scientific achievement”. There are 11 other categories and three special […]

Scholars join forces on anti-cancer drug

Two Gates Cambridge Scholars have joined forces to work on a drug candidate that has the potential to replace one of the most widely used cancer drugs around the world. Dr Anand Jeyasekharan [2004], who did his PhD in Oncology, and Dr Chandler Robinson [2009] who did an MBA at Cambridge, will collaborate on a […]

Making the experiences of imprisoned women activists visible

Growing up in a small town in Bengal, Jigisha Bhattacharya [2022] developed a particular sensitivity to marginalised groups and conflicts between different communities and identities from an early age.  It is this interest and her experience of political protests at university, combined with a longstanding curiosity about the links between politics and the arts, that […]

The study of images in the computer age

Scholar-Elect Tristan Dot [2022] grew up with an interest in computer science and a passion for art history. As time evolved he began to see the similarities between computer vision and art history and has created his own works of art, using computer-generated images.  He says: “Art history is the study of images and so […]